Medtronic commenced U.S. launch of the Adaptix™ Interbody System, the first navigated titanium implant with Titan nanoLOCK™ Surface Technology. Adaptix, based on the legacy Capstone™ Spinal System, includes features for increased strength, subsidence resistance, easy insertion and data-backed bone growth.
Titan Spine, acquired in 2019, pioneered nanoLOCK technology that is the first to demonstrate the elements to be considered a nanotechnology for spinal devices as outlined in the FDA nanotechnology guidance document.
Adaptix is compatible with the Medtronic navigation platform (StealthStation™ Navigation and O-arm™ imaging) and the newly-released Grafton™ DBF Inject, a graft delivery syringe that delivers an osteoinductive demineralized bone matrix into the surgical site.
"Adaptix Interbody System is an exciting addition to our portfolio that leads with our Titan nanoLOCK Surface Technology," said Sharrolyn Josse, Vice President and General Manager of Medtronic Core Spine and Biologics division, which is part of the Restorative Therapies Group at Medtronic. "It is a fully navigated procedure, leveraging our leadership in navigation."